78
Registered trials
32
Recruiting
32
Completed trials
58
Sponsors
25
Countries
Phase III:
30
Phase II/III:
5
Phase II:
28
Phase I/II:
2
Phase III/IV:
1
Phase IV:
12
Oversight events:
6 serious breaches
38 temporary halts
4 urgent safety measures
1 unexpected event
4 corrective measures
across 13 trials
View oversight register →
Indications tested
Rheumatoid arthritis
6
Juvenile idiopathic arthritis
2
Dermatomyositis
2
Polymyositis
2
B precursor type acute leukaemia
1
Idiopathic inflammatory myopathy
1
Crohn´s disease
1
Non-small cell lung cancer
1
Colorectal cancer metastatic
1
Giant cell arteritis
1
Medulloblastoma
1
Secondary progressive multiple sclerosis
1
Sponsors using this IMP
Fondazione Gimema Franco Mandelli Onlus
5
Centre Hospitalier Universitaire De Nantes
4
Assistance Publique Hopitaux De Paris
3
GPOH gGmbH
3
Janssen - Cilag International
3
Karolinska University Hospital
3
Amsterdam UMC Stichting
2
Associazione Italiana Ematologia Oncologia Pediatrica
2
Charite Universitaetsmedizin Berlin KöR
2
Diakonhjemmet Sykehus AS
2
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
2
Medical University Of Lodz
2
All trials
78 total-
SIOP PNET 5 medulloblastoma Pending
Showing 1–24 of 78 trials